Rare Disease Groups Welcome FDA’s Embrace of ‘Real World’ Data in Clinical Trials
In his 10 months on the job, Commissioner Scott Gottlieb of the U.S. Food and Drug Administration is earning praise for his efforts to make clinical trials for new ... Read more